Kevin P. P. Mahoney
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kevin P. P. Mahoney has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Rebecca Jane Miriam Goss
School of Chemistry, University of St. Andrews, St. Andrews, Fife, KY16 9ST, UK
2 shared publications - Alexandra Martha Zoya Slawin
EaStCHEM School of Chemistry University of St Andrews St Andrews UK
1 shared publication - David Bradford Cordes
EaStCHEM School of Chemistry, University of St Andrews, North Haugh, St Andrews KY16 9ST, Fife, UK
1 shared publication Duncan R. M. Smith
School of Chemistry and BSRC, University of St Andrews, St Andrews, KY16 9ST, UK Fax: +44(1334)463808
1 shared publicationEmma J. A. Bogosyan
School of Chemistry and BSRC, University of St Andrews, St Andrews, KY16 9ST, UK Fax: +44(1334)463808
1 shared publication- George Richard Stephenson
University of East Anglia
1 shared publication
Latest Publications
- Open Access
- 19 June 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (6)
Cycloadditions as a Sweet Route to ‘Double C-Glycosylation’
Pharmaceuticals, such as the antibiotic erythromycin, and sodium-dependent glucose transporter (SGLT1 & SGTL2) inhibitors such as Bexagliflozin (diabetes) and Sotagliflozin (heart disease), are often sugar-decorated (glycosylated). Glycosylation is a key component of the binding motif in SGLT inhibitors and, in natural products, glycosylation often confers improved bioactivity and bioavailability. Whilst a single C-glycoside link between a sugar moiety and its aglycone core is a common feature in natural products isolated to date, only a small number, including the antibiotics granaticin and sarubicin, are covalently bonded twice to a single sugar moiety. The way in which this “double C-glycosylation” is naturally mediated is not yet known, yet has been speculated on. Here, we report the exploration and development of a potentially biomimetic procedure that utilises intermolecular cycloaddition chemistry to access new “double C-glycosylated” products and enables the creation of bridged polycyclic ethers from a common maltol-derived oxidopyrylium salt precursor.
- 19 June 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (6)
Open AccessCycloadditions as a Sweet Route to ‘Double C-Glycosylation’
Pharmaceuticals, such as the antibiotic erythromycin, and sodium-dependent glucose transporter (SGLT1 & SGTL2) inhibitors such as Bexagliflozin (diabetes) and Sotagliflozin (heart disease), are often sugar-decorated (glycosylated). Glycosylation is a key component of the binding motif in SGLT inhibitors and, in natural products, glycosylation often confers improved bioactivity and bioavailability. Whilst a single C-glycoside link between a sugar moiety and its aglycone core is a common feature in natural products isolated to date, only a small number, including the antibiotics granaticin and sarubicin, are covalently bonded twice to a single sugar moiety. The way in which this “double C-glycosylation” is naturally mediated is not yet known, yet has been speculated on. Here, we report the exploration and development of a potentially biomimetic procedure that utilises intermolecular cycloaddition chemistry to access new “double C-glycosylated” products and enables the creation of bridged polycyclic ethers from a common maltol-derived oxidopyrylium salt precursor.
- 9 July 2014
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 46 (16) , 2122-2132
Access to High Value Natural and Unnatural Products through Hyphenating Chemical Synthesis and Biosynthesis
Access to natural products and their analogues is crucial. Such compounds have, for many years, played a central role in the area of drug discovery as well as in providing tools for chemical biology. The ability to quickly and inexpensively acquire genome sequences has accelerated the field of natural product research. Access to genomic data coupled with new technologies for the engineering of organisms is resulting in the identification of large numbers of previously undiscovered natural products as well as an increased understanding of how the biosynthetic pathways responsible for the biogenesis of these compounds may be manipulated. This short review summarizes and reflects upon approaches to accessing natural products and has a particular focus on approaches combining molecular biology and synthetic chemistry. 1 Introduction 2 CHEM: Total Synthesis 3 BIO-CHEM: Semi-Synthesis 4 CHEM-BIO: Precursor Directed Biosynthesis 5 BIO-CHEM-BIO: Mutasynthesis 6 BIO-BIO: Combinatorial Biosynthesis 7 BIO-BIO-CHEM: Genochemetics: Gene Expression Enabling Synthetic Diversification 8 Conclusions and Future Directions in Natural Product Analogue Generation
- 9 July 2014
- Published by Georg Thieme Verlag KG in Synthesis
- Vol. 46 (16) , 2122-2132
Access to High Value Natural and Unnatural Products through Hyphenating Chemical Synthesis and Biosynthesis
Access to natural products and their analogues is crucial. Such compounds have, for many years, played a central role in the area of drug discovery as well as in providing tools for chemical biology. The ability to quickly and inexpensively acquire genome sequences has accelerated the field of natural product research. Access to genomic data coupled with new technologies for the engineering of organisms is resulting in the identification of large numbers of previously undiscovered natural products as well as an increased understanding of how the biosynthetic pathways responsible for the biogenesis of these compounds may be manipulated. This short review summarizes and reflects upon approaches to accessing natural products and has a particular focus on approaches combining molecular biology and synthetic chemistry. 1 Introduction 2 CHEM: Total Synthesis 3 BIO-CHEM: Semi-Synthesis 4 CHEM-BIO: Precursor Directed Biosynthesis 5 BIO-CHEM-BIO: Mutasynthesis 6 BIO-BIO: Combinatorial Biosynthesis 7 BIO-BIO-CHEM: Genochemetics: Gene Expression Enabling Synthetic Diversification 8 Conclusions and Future Directions in Natural Product Analogue Generation